INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
InfuSystem Holdings, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$13.74+0.34 (+2.54%)
Close on Oct 19, 2026
- Market cap
- $287.44M
- P/E (TTM)
- 33.5
- Dividend yield
- –
InfuSystem Holdings, Inc revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Patient Services and Device Solutions | $113.08M | $106.30M | $98.74M | $85.43M | $80.70M | – | – | – | 78.8% | +6.4% |
| Patient Services | $86.53M | $80.38M | $76.54M | $68.88M | $65.60M | – | – | – | 60.3% | +7.7% |
| Device Solutions | $64.10M | $61.74M | $55.83M | $47.51M | $42.54M | – | – | – | 44.7% | +3.8% |
| ITS Segment | – | – | – | $68.88M | $65.60M | $61.07M | $51.54M | $41.44M | – | – |
| DME Services Segment | – | – | – | $47.51M | $42.54M | $41.69M | $33.36M | $29.25M | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Direct Payer Rentals | – | – | – | – | $29.30M | $28.53M | $24.12M | – | – | – |
| Services | – | – | – | – | $4.72M | $2.24M | $2.15M | – | – | – |
| Product Sales | – | – | – | – | $15.51M | $17.36M | $14.34M | – | – | – |
| Third-Party Payer Rentals | – | – | – | – | $52.85M | $49.27M | $40.51M | – | – | – |
By region
From the segment and revenue-disaggregation notes of InfuSystem's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.